title: Composite indicator: new tool for monitoring RNTCP performance in India.
abstract: India's Revised National Tuberculosis Control Programme (RNTCP) used the international benchmarks of 70% case detection rate and 85% treatment success rate among new smear-positive tuberculosis (TB) cases for assessing programme performance. This approach overemphasises outcomes and focuses on quantitative benchmarks without sufficient regard to developing systems to monitor appropriate programme practice to achieve a minimum standard of TB care services. The RNTCP has developed a novel composite indicator tool based on a logical framework pathway to move beyond narrow-focused outcome indicators such as case detection to encourage a broad-based analysis of programme implementation. The constituent indicators are from routinely monitored information, spanning input, process, output and outcome indicators across various thematic categories of the RNTCP.
authors.affiliation: <label>*</label>Central TB Division, Directorate of General Health Services, Ministry of Health and Family Welfare, New Delhi, India.
authors.forename: A K
authors.initials: AK
authors.lastname: Bansal
authors.affiliation: <label>*</label>Central TB Division, Directorate of General Health Services, Ministry of Health and Family Welfare, New Delhi, India.
authors.forename: N
authors.initials: N
authors.lastname: Kulshrestha
authors.affiliation: <label>*</label>Central TB Division, Directorate of General Health Services, Ministry of Health and Family Welfare, New Delhi, India.
authors.forename: S B
authors.initials: SB
authors.lastname: Nagaraja
authors.affiliation: <label>*</label>Central TB Division, Directorate of General Health Services, Ministry of Health and Family Welfare, New Delhi, India.
authors.forename: K
authors.initials: K
authors.lastname: Rade
authors.affiliation: <label><sup>†</sup></label>Office of the WHO Representative in India, New Delhi, India.
authors.forename: A
authors.initials: A
authors.lastname: Choudhary
authors.affiliation: <label>*</label>Central TB Division, Directorate of General Health Services, Ministry of Health and Family Welfare, New Delhi, India.
authors.forename: M
authors.initials: M
authors.lastname: Parmar
authors.affiliation: <label><sup>†</sup></label>Office of the WHO Representative in India, New Delhi, India.
authors.forename: S A
authors.initials: SA
authors.lastname: Nair
authors.affiliation: <label><sup>§</sup></label>Bill & Melinda Fates Foundation, New Delhi, India.
authors.forename: P K
authors.initials: PK
authors.lastname: Dewan
authors.affiliation: <label><sup>‡</sup></label>Department of Preventive & Social Medicine, SMS Medical College, Jaipur.
authors.forename: R
authors.initials: R
authors.lastname: Yadav
authors.affiliation: <label><sup>¶</sup></label>Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
authors.forename: P K
authors.initials: PK
authors.lastname: Moonan
authors.affiliation: <label>*</label>Central TB Division, Directorate of General Health Services, Ministry of Health and Family Welfare, New Delhi, India.
authors.forename: A
authors.initials: A
authors.lastname: Kumar
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D019985:Benchmarking; D006801:Humans; D007194:India; D009313:National Health Programs; D016730:Program Development; D015397:Program Evaluation; D019984:Quality Indicators, Health Care; D013183:Sputum / Q000382:microbiology; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents